更多开发者作品
Gastroenterology
最新
| 1. | Sucrase isomaltase dysfunction reduces sucrose intake in mice and humans | Peter Aldiss, Leire Torices, Stina Ramne, Marit Eika Jørgensen, Sucrase-Isomaltase Working Group, Mauro D’Amato, Mette K. Andersen | |
| 2. | Exploring the Potential of Real-Time Audio-Visual Interactions of ChatGPT-4o in Endoscopy Training and Practice | Qiqi Wu | |
| 3. | CREEPING FAT-DERIVED FREE FATTY ACIDS INDUCE HYPERPLASIA OF INTESTINAL MUSCULARIS PROPRIA MUSCLE CELLS – A NOVEL LINK BETWEEN FAT AND INTESTINAL STRICTURE FORMATION IN CROHN’S DISEASE | Weiwei Liu, Ren Mao, Thi Hong Nga Le, Gail West, Venkateshwari Varadharajan, Rakhee Banerjee, Genevieve Doyon, Pranab Mukherjee, Quang Tam Nguyen, Anny Mulya, Julie H. Rennison, Ilyssa O. Gordon, Michael Cruise, Shaomin Hu, Doug Czarnecki, Thomas Plesec, Jyotsna Chandra, Suhanti Banerjee, Jie Wang, William J. Massey, Idan Goren, Si-Nan Lin, Satya Kurada, Benjamin L. Cohen, Taha Qazi, Stefan D. Holubar, Jeremy Lipman, Arielle Kanters, Christy M. Gliniak, Philipp E. Scherer, Min-Hu Chen, Britta Siegmund, Andrei I. Ivanov, Claudio Fiocchi, David R. Van Wagoner, J. Mark Brown, Florian Rieder | |
| 4. | An Unexpected Cause of Fistulizing Small Intestinal Disease | Saam Dilmaghani, Rondell P. Graham, Seth Sweetser | |
| 5. | Phase 3 validation of PAaM for hepatocellular carcinoma risk stratification in cirrhosis | Naoto Fujiwara, Camden Lopez, Tracey L. Marsh, Indu Raman, Cesia A. Marquez, Subhojit Paul, Sumit K. Mishra, Naoto Kubota, Courtney Katz, Hiroaki Kanzaki, Michael Gonzalez, Lisa Quirk, Sneha Deodhar, Pratibha Selvakumar, Prithvi Raj, Neehar D. Parikh, Lewis R. Roberts, Myron E. Schwartz, Mindie H. Nguyen, Alex S. Befeler, Stephanie Page-Lester, Sudhir Srivastava, Ziding Feng, K. Rajender Reddy, Saira Khaderi, Sumeet K. Asrani, Fasiha Kanwal, Hashem B. El-Serag, Jorge A. Marrero, Amit G. Singal, Yujin Hoshida | |
| 6. | Corrigendum | | |
| 7. | Adverse Events Associated with Endoscopic Retrograde Cholangiopancreatography: Systematic Review and Meta-analysis | Kirles Bishay, Zhao Wu Meng, Rishad Khan, Mehul Gupta, Yibing Ruan, Marcus Vaska, Jordan Iannuzzi, Dylan E. O’Sullivan, Brittany Mah, Arun C.R. Partridge, Amanda M. Henderson, Howard Guo, Sunil Samnani, Max DeMarco, Yuhong Yuan, B. Joseph Elmunzer, Rajesh N. Keswani, Sachin Wani, Zachary L. Smith, Ronald J. Bridges, Steven J. Heitman, Robert J. Hilsden, Darren R. Brenner, Grigorios I. Leontiadis, Nauzer Forbes | |
| 8. | An intriguing case of hepatosplenic lesions and pneumonia during anti-TNF therapy for IBD. | Gabriel Luiz de Almeida Souza, Vinicius Andrade Chebli, Julio Maria Fonseca Chebli | |
| 9. | A Rare Case of Enterocolitis with a Rare Cause | Hirotaka Nakamura, Daisuke Watanabe, Yuzo Kodama | |
| 10. | Hacking Death in Dublin | Seamus O'Mahony | |
| 11. | The new horizon of Clostridioides difficile infection treatment | Ed.J. Kuijper, Kevin W. Garey | |
| 12. | FIT-positive individuals: is timely upper GI endoscopy necessary? | Yunmeng Nie, Jianyu Lv, Junbin Yan | |
| 13. | Comments on “Risk of Cancers Proximal to the Colon in Fecal Immunochemical Test Positive Screenees in a Colorectal Cancer Screening Program” | Xian-hui Zhang, Yang Liu, Yu-xiang Gao, James Cheng-Chung Wei, Li-yun Zhang | |
| 14. | Esophagogastroduodenoscopy for Positive Fecal Immunochemical Test Screeners? Much Done, More to Be Considered. | Lizhi Yi, Xiaoli Ren, Zhengyu Cheng | |
| 15. | Comment on “Risk of Cancers Proximal to the Colon in Fecal Immunochemical Test Positive Screenees in a Colorectal Cancer Screening Program” | Jixuan Wu, Zili Zhang, Lei Zhang | |
| 16. | Reevaluating Confounders and Risk Interpretation in FIT-Positive Cancer Screening | Jiashu Han, Dan Shan | |
| 17. | Reply to Nie et al, Zhang et al, Yi et al, Wu et al, and Han andShan | Willemijn de Klaver, Manon van der Vlugt, Evelien Dekker | |
| 18. | An Unusual Case of Gastric Multiple Lesions with Skin and Joint Abnormalities | Haoran Jin, Feifan Chen, Jinlin Yang | |
| 19. | CME Exam 1: Gastrointestinal Biofilms: Endoscopic Detection, Disease Relevance, and Therapeutic Strategies | | |
| 20. | Cover 1 | | |
| 21. | Editorial Board | | |
| 22. | Disparities in Gastrointestinal Health for US Immigrant Populations, and Strategies to Address These Disparities | Miguel Malespin, Saikiran M. Kilaru | |
| 23. | Table of Contents | | |
| 24. | Elsewhere in The AGA Journals (Preview Section) | | |
| 25. | A HIGH-RESOLUTION MICROENDOSCOPE IMPROVES ESOPHAGEAL CANCER SCREENING AND SURVEILLANCE: IMPLICATIONS FOR UNDERSERVED GLOBAL SETTINGS BASED ON AN INTERNATIONAL, RANDOMIZED CONTROLLED TRIAL | Mimi C. Tan, Zhengqi Li, Kalpesh K. Patel, Fan Zhang, Xinying Yu, Xueshan Wang, Daniel G. Rosen, Sanford M. Dawsey, Liyan Xue, Chin Hur, Richard A. Schwarz, Imran Vohra, Yubo Tang, Mengfen Wu, Tao Wang, Jennifer Carns, Hong Xu, Rebecca R. Richards-Kortum, Guiqi Wang, Sharmila Anandasabapathy | |
| 26. | The management of internal fistulizing Crohn’s disease in a child: more than meets the eye | Kelsey Jones, Luba Plotkin, Stavros Loukogeorgakis, Ruth Cytter-Kuint, Austen Worth, Dan Turner | |
| 27. | Differing Epithelial and Immunologic Activation Patterns Following Food Reintroduction Reveal Different Transcriptional Profiles in Active Eosinophilic Esophagitis | Ashley L. Pyne, Amiko M. Uchida, Mark W. Hazel, Maria A. Pletneva, Kristina Allen-Brady, Kathryn A. Peterson | |
| 28. | Multi-cohort analysis reveals altered archaea in colorectal cancer fecal samples across populations | Tianhui Li, Olabisi Oluwabukola Coker, Yang Sun, Shiyu Li, Chuanfa Liu, Yufeng Lin, Sunny H. Wong, Yinglei Miao, Joseph JY. Sung, Jun Yu | |
| 29. | Reply | Ingo Steinbrück | |
| 30. | Evaluation of the Cold Versus Hot Snare Endoscopic Resection of Large Nonpedunculated Colorectal Polyps in the German CHRONICLE Trial | Yu Yang, Yaling Li, Chengzi Huang, Ting Yu, Jun Li | |
| 31. | Alcohol-Associated Liver Disease: Managing the Dual Pathology of Liver Disease and of Alcohol Use Disorder | Juan Pablo Arab, Alexandre Louvet, Maja Thiele, Gerald S. Winder, Robert J. Wong, Ashwani K. Singal | |
| 32. | Detailed Information on Cold Snare Resection in Large Colorectal Polyps | Koki Nakajima, Hiroaki Saito, Yoshitaka Nishikawa | |
| 33. | Assessing the Preventative Effects of Vonoprazan Relative to Intravenous Proton Pump Inhibitors Following Endoscopic Intervention in Peptic Ulcers | Wei-Zheng Tang, Tai-Hang Liu, Ying-Bo Li | |
| 34. | Reply | Tanawat Geeratragool, Uayporn Kaosombatwattana | |
| 35. | Faecalibacterium prausnitzii Is Associated With Clinical Response to Immune Checkpoint Inhibitors in Patients With Advanced Gastric Adenocarcinoma: Results of Microbiota Analysis of PRODIGE 59-FFCD 1707-DURIGAST Trial | Marius Bredon, Karine Le Malicot, Christophe Louvet, Ludovic Evesque, Daniel Gonzalez, David Tougeron, Harry Sokol | |
| 36. | Burn the Fat: Colon Cancer Tumors Are Skilled at Lipid Storage During Obesity | Arianne L. Theiss, Christopher S. Williams | |
| 37. | CHRONICLE Trial: How Cool Is Cold Snaring for Endoscopic Mucosal Resection? | Avinash Tiwari | |
| 38. | Enhancing Cold Snare Endoscopic Mucosal Resection: Addressing Efficacy Concerns and Margin Management | Jia Xu, Xiaowei Tang | |
| 39. | Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Ulcerative Colitis: 2024 American Gastroenterological Association Evidence Synthesis | Ashwin N. Ananthakrishnan, M. Hassan Murad, Frank I. Scott, Manasi Agrawal, John P. Haydek, Berkeley N. Limketkai, Edward V. Loftus, Siddharth Singh | |
| 40. | Prospective Analysis of Liver Stiffness Measurement by Vibration Controlled Transient Elastography as a Predictor of Outcomes in Biliary Atresia | Jean P. Molleston, Nathan P. Goodrich, Wen Ye, Daniel H. Leung, Ronald J. Sokol, Benjamin L. Shneider, Children Force Outcomes Working Group | |
| 41. | A “How-to” Guide For Establishing an Effective Trainee Mentorship Program | Kirstie Lithgow, Jordan Iannuzzi, Kelle Hurd, Suqing Li | |
| 42. | Insights Into the Protective Role of GLP-1RAs in the Treatment of Type 2 Diabetes Mellitus: Implications for Hepatocellular Carcinoma and Hepatic Dysfunction | Ziyi Wang, Jun Li, Yaling Li | |
| 43. | Methodology of Study on Glucagon-like Peptide-1 Receptor Agonists and Hepatocellular Carcinoma Risk | James Cheng-Chung Wei, Poi Kuo, Qi Mei | |
| 44. | Comments on “Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes” | James Cheng-Chung Wei, Ching-Nung Wu, Wei-Chun Cheng | |
| 45. | Evolutionary Medicine for Chronic Inflammatory Diseases of the Gut: More Than a Clinical Fantasy? | Nadia Andrea Andreani, Daniel Unterweger, Stefan Schreiber, John F. Baines | |
| 46. | GLP-1 Receptor Agonists' Role in Reducing Hepatocellular Carcinoma Risk | Zaoqu Liu, Dan Shan, Xinwei Han | |
| 47. | AGA Clinical Practice Update on Advances in Per-Oral Endoscopic Myotomy (POEM) and Remaining Questions—What We Have Learned in the Past Decade: Expert Review | Dennis Yang, Robert Bechara, Christy M. Dunst, Vani J.A. Konda | |
| 48. | In Memoriam: Ikuo Hirano, MD | Nirmala Gonsalves, Steven Flamm, Gary W. Falk, David A. Katzka | |
| 49. | Reply | Rong Xu | |
| 50. | Neurons on a Mission: Glial Global Positioning System for the Gut Reboot! | Chalystha Yie Qin Lee, Kara Gross Margolis | |
| 51. | Placebo Rates in Crohn’s Disease Randomized Clinical Trials: An Individual Patient Data Meta-analysis | Virginia Solitano, Malcolm Hogan, Siddharth Singh, Silvio Danese, Laurent Peyrin-Biroulet, Guangyong Zou, Yuhong Yuan, Bruce E. Sands, Brian G. Feagan, Parambir S. Dulai, Neeraj Narula, Christopher Ma, Vipul Jairath | |
| 52. | Longitudinal Evaluation of Individuals With Severe Alpha-1 Antitrypsin Deficiency (Pi∗ZZ Genotype) | Malin Fromme, Audrey Payancé, Mattias Mandorfer, Katrine H. Thorhauge, Monica Pons, Marc Miravitlles, Jan Stolk, Bart van Hoek, Guido Stirnimann, Sona Frankova, Jan Sperl, Andreas E. Kremer, Barbara Burbaum, Christina Schrader, Amine Kadioglu, Michelle Walkenhaus, Carolin V. Schneider, Fabienne Klebingat, Lorenz Balcar, Naomi N. Kappe, Benedikt Schaefer, Joanna Chorostowska-Wynimko, Elmar Aigner, Sophie Gensluckner, Philipp Striedl, Pauline Roger, John Ryan, Suzanne Roche, Marius Vögelin, Aftab Ala, Heike Bantel, Jef Verbeek, Zoe Mariño, Michael Praktiknjo, Tom J.G. Gevers, Philipp A. Reuken, Thomas Berg, Jacob George, Münevver Demir, Tony Bruns, Christian Trautwein, Heinz Zoller, Michael Trauner, Joan Genesca, William J. Griffiths, Virginia Clark, Aleksander Krag, Alice M. Turner, Noel G. McElvaney, Pavel Strnad | |
| 53. | Unveiling a Critical Role of IL-7 in Celiac Disease — Insights From a Novel Human Autoimmune Organoid Model | Daniel Kotlarz | |
| 54. | Comparing the Performance of Commonly Used Fecal Immunochemical Tests | Nauzer Forbes | |
| 55. | Eosinophils Are Just the Tip of the Iceberg for Eosinophilic Esophagitis | Eric E. Low, Rena Yadlapati | |
| 56. | The First Approved Therapy in Infants and Young Children With EoE — Now the Big Question: Where Will Dupilumab Fit Into Real-World Practice? | Eric E. Low, Rena Yadlapati | |
| 57. | Leucine-Rich Alpha-2-Glycoprotein 1 Promotes Metastatic Colorectal Cancer Growth Through Human Epidermal Growth Factor Receptor 3 Signaling | Moeez Rathore, Kimberly Curry, Wei Huang, Michel’le Wright, Daniel Martin, Jiyeon Baek, Derek Taylor, Masaru Miyagi, Wen Tang, Hao Feng, Yamu Li, Zhenghe Wang, Hallie Graor, Joseph Willis, Elizabeth Bryson, Christina S. Boutros, Omkar Desai, Bianca Islam, Lee M. Ellis, Stephen E. Moss, Jordan M. Winter, John Greenwood, Rui Wang | |
| 58. | Immune Checkpoint Inhibitor–Induced Colitis | Anusha S. Thomas, Yang Lu, Mathew Campbell, John A. Thompson, Dongfeng Tan, David M. Faleck, Yinghong Wang | |
| 59. | Persistent Severe Abdominal Pain in a 40-Year-Old Male Patient | Shin Kashima, Yuki Kamikokura, Kentaro Moriichi | |
| 60. | Engineering Therapeutic Regulatory T Cells to Overexpress G Protein-Coupled Receptor 15 Improves Functional Fitness for In Vivo Gut Homing | Tanja M. Müller, Li-Juan Liu, Manuel Wiesinger, TRR241 Working Group, Markus F. Neurath, Caroline J. Voskens, Sebastian Zundler | |
| 61. | Novel Immune Manipulators for IBD: Miniproteins! | Eytan Wine | |
| 62. | Early Life Exposure to Parental Crohn’s Disease Is Associated With Offspring’s Gut Microbiome, Gut Permeability, and Increased Risk of Future Crohn’s Disease | Sun-Ho Lee, Maham Bushra, Lanhui Qiu, Anne M. Griffiths, Williams Turpin, Kenneth Croitoru, Crohn’s Colitis Canada Genetic Environmental And Microbial Consortium, Maria Abreu, Paul Beck, Charles Bernstein, Kenneth Croitoru, Leo Dieleman, Brian Feagan, Anne Griffiths, David Guttman, Kevan Jacobson, Gilaad Kaplan, Denis O. Krause, Karen Madsen, John Marshall, Paul Moayyedi, Mark Ropeleski, Ernest Seidman, Mark Silverberg, Scott Snapper, Andy Stadnyk, A. Hillary Steinhart, Michael Surette, Dan Turner, Thomas Walters, Bruce Vallance, Guy Aumais, Alain Bitton, Maria Cino, Jeff Critch, Lee Denson, Colette Deslandres, Wael El-Matary, Hans Herfarth, Peter Higgins, Hien Q. Huynh, Jeff Hyams, David Mack, Jerry McGrath, Anthony Otley, Remo Panancionne, Maria Abreu, Guy Aumais, Robert Baldassano, Charles Bernstein, Maria Cino, Lee Denson, Colette Deslandres, Wael El-Matary, Anne M. Griffiths, Charlotte Hedin, Hans Herfarth, Peter Higgins, Seamus Hussey, Hien Q. Huynh, Kevan Jacobson, David Keljo, David Kevans, Charlie Lees, David Mack, John Marshall, Jerry McGrath, Sanjay Murthy, Anthony Otley, Remo Panaccione, Nimisha Parekh, Sophie Plamondon, Graham Radford-Smith, Mark Ropeleski, Joel Rosh, David Rubin, Michael Schultz, Ernest Seidman, Corey Siegel, Scott Snapper, A. Hillary Steinhart, Dan Turner | |
| 63. | The Educational Impact of the GI Hospitalist Model on Gastroenterology Fellowship Training | Ryan Flanagan, Calley Levine, Kenneth Hung, Michelle Hughes, Cassandra D.L. Fritz, David Wan, Daniel J. Stein | |
| 64. | Use of Large Language Models to Identify Surveillance Colonoscopy Intervals—A Feasibility Study | Vedant Acharya, Vignesh Kumaresan, Jonathan England, Shivan Mehta, Daniel Sussman, Amar Deshpande | |
| 65. | Safety and Tolerability of CP101, a Full-Spectrum, Oral Microbiome Therapeutic for the Prevention of Recurrent Clostridioides difficile Infection: A Phase 2 Randomized Controlled Trial | Jessica R. Allegretti, Colleen R. Kelly, Thomas Louie, Monika Fischer, Susy Hota, Bharat Misra, Nick W. Van Hise, Eugene Yen, Jeffrey S. Bullock, Michael Silverman, Ian Davis, Sarah K. McGill, Darrell S. Pardi, Robert Orenstein, Ari Grinspan, Najwa El-Nachef, Paul Feuerstadt, Thomas J. Borody, Sahil Khanna, Shrish Budree, Zain Kassam | |
| 66. | Hidden Footprints in Ascites: Lessons From a Mystery Enduring for 200 Years | Yoichi Nakatsu, Makoto Furihata, Taro Osada | |
| 67. | Corrigendum | | |
| 68. | Surveillance for Hepatocellular Carcinoma in Cirrhosis: End of Monopoly for Serum Alpha Fetoprotein | Lung-Yi Mak, Man-Fung Yuen | |
| 69. | A Brain-Gut Pathway for Stress-Induced Microbiome Change | Sarah A. Najjar, Kara Gross Margolis | |
| 70. | Multimodal Profiling of Peripheral Blood Identifies Proliferating Circulating Effector CD4+ T Cells as Predictors for Response to Integrin α4β7–Blocking Therapy in Inflammatory Bowel Disease | Veronika Horn, Camila A. Cancino, Lisa Maria Steinheuer, Benedikt Obermayer, Konstantin Fritz, Anke L. Nguyen, Kim Susan Juhran, Christina Plattner, Diana Bösel, Lotte Oldenburg, Marie Burns, Axel Ronald Schulz, Mariia Saliutina, Eleni Mantzivi, Donata Lissner, Thomas Conrad, Mir-Farzin Mashreghi, Sebastian Zundler, Elena Sonnenberg, Michael Schumann, Lea-Maxie Haag, Dieter Beule, Lukas Flatz, TRR241 IBDome Consortium, Zlatko Trjanoski, Geert D’Haens, Carl Weidinger, Henrik E. Mei, Britta Siegmund, Kevin Thurley, Ahmed N. Hegazy | |
| 71. | The Impact of Population-Based Helicobacter pylori Test-To-Treat Strategies on Gastric Cancer Outcomes | Corey J. Ketchem | |
| 72. | It Runs in the Family: What Studying Unaffected Individuals in Simplex and Multiplex Families Tells Us About Inflammatory Bowel Disease Development | Jonas J. Rudbaek, Aleksejs Sazonovs, Tine Jess | |
| 73. | Reply | Hanseul Kim, Long H. Nguyen | |
| 74. | Methodological Aspects of "Thoracoabdominal Wall Motion–Guided Biofeedback Treatment of Abdominal Distention: A Randomized Placebo-Controlled Trial" | Manjeet Kumar Goyal, Karan Sachdeva, Omesh Goyal | |
| 75. | Reply | Fernando Azpiroz | |
| 76. | Evaluating Research Strategy and Inclusion Criteria of Long-term Proton Pump Inhibitor Use | Yanqing Niu, Xiaherezhati Aihaiti, Man Li | |
| 77. | Reply | Anna-Klara Wiklund, Giola Santoni, Jesper Lagergren | |
| 78. | Refining Biofeedback in Gastroenterology: Enhancing Precision in Thoracoabdominal Motion Studies | Junkun Zhu | |
| 79. | Helicobacter pylori Eradication Treatment Might Help Reduce the Risk of Esophageal Adenocarcinoma | Hui Chen, Chuanli Ren | |
| 80. | Enhancing Research on Helicobacter pylori Eradication and Esophageal Adenocarcinoma Risk: A Call for Broader Studies and Methodological Rigor | Xiaolong Guo, Yongfeng Wang, Hui Cai | |
| 81. | Interventions for Improving Quality of Colonoscopy | Qing-Hua Wang, Min Zhang, Hua Chen, Wei Han | |
| 82. | Advancing Biofeedback Therapy in Abdominal Distention: Recommendations for Methodological Improvements and Increased Generalizability | Xiaolong Guo, Yongfeng Wang, Yuan Yuan | |
| 83. | Focus on Psychological Intervention: Insights from Thoracoabdominal Wall Motion–Guided Biofeedback Treatment of Abdominal Distention | Chenhong Tian, Changlin Zhai, Haihua Pan | |
| 84. | Detection of Gastrointestinal Bleeding With Large Language Models to Aid Quality Improvement and Appropriate Reimbursement | Neil S. Zheng, Vipina K. Keloth, Kisung You, Daniel Kats, Darrick K. Li, Ohm Deshpande, Hamita Sachar, Hua Xu, Loren Laine, Dennis L. Shung | |
| 85. | Obesity-Facilitated Colon Cancer Progression Is Mediated by Increased Diacylglycerol O-Acyltransferases 1 and 2 Levels | Jenisha Ghimire, Morgan E. Collins, Patricia Snarski, Angelle N. King, Emmanuelle Ruiz, Rida Iftikhar, Harrison M. Penrose, Krzysztof Moroz, Tyler Rorison, Melody Baddoo, Muhammad Anas Naeem, Arnold H. Zea, Scott T. Magness, Erik F. Flemington, Susan E. Crawford, Suzana D. Savkovic | |
| 86. | Myosin Vb Traffics P-Glycoprotein to the Apical Membrane of Intestinal Epithelial Cells | Sarah A. Dooley, Elena Kolobova, Andreanna Burman, Izumi Kaji, Jessica R. Digrazia, Rachel Stubler, Anna Goldstein, Charulekha Packirisamy, Alexander W. Coutts, Milena Saqui-Salces, Nan Gao, Melinda A. Engevik, Mitchell D. Shub, James R. Goldenring, Amy C. Engevik | |
| 87. | A Phase 3 Biomarker Validation of GALAD for the Detection of Hepatocellular Carcinoma in Cirrhosis | Tracey L. Marsh, Neehar D. Parikh, Lewis R. Roberts, Myron E. Schwartz, Mindie H. Nguyen, Alex Befeler, Stephanie Page-Lester, Nabihah Tayob, Sudhir Srivastava, Jo Ann Rinaudo, Amit G. Singal, K. Rajender Reddy, Jorge A. Marrero | |
| 88. | Reply | Timothy B. Gardner, Walter G. Park, Peter J. Allen | |
| 89. | The Brain and the Immune System: A Dynamic Duo in Detecting and Defending | Lin Y. Hung, Kara Gross Margolis | |
| 90. | Comments on “Diagnosis and Management of Pancreatic Cysts” | Santhi Swaroop Vege | |
| 91. | Reevaluating Stemness in the Intestinal Crypt | Samuel Asfaha, Nicola L. Jones | |
| 92. | EUS-Guided Rendezvous Versus Needle-Knife Sphincterotomy After Difficult Biliary Cannulation in ERCP for Benign Disease | Nauzer Forbes | |
| 93. | Dual Targeting of Syndecan-1 and Glucose Transporter-1 With a Novel Lipid-Based Delivery System Enhances Therapeutic Efficacy and Overcomes Chemoresistance in Pancreatic Ductal Adenocarcinoma | Hari Krishna Rachamala, Naga Malleswara Rao Nakka, Ramcharan Singh Angom, Santanu Bhattacharya, Krishnendu Pal, Debabrata Mukhopadhyay | |
| 94. | Stress Ulcer Prophylaxis in the Intensive Care Unit: More Evidence of Benefit | Rishad Khan | |
| 95. | Where do Noninvasive Colorectal Cancer Tools “FIT” Alongside Colonoscopy in the Surveillance of High-Risk Patients? | Kevin J. Monahan | |
| 96. | AGA Clinical Practice Update on Integrating Potassium-Competitive Acid Blockers Into Clinical Practice: Expert Review | Amit Patel, Loren Laine, Paul Moayyedi, Justin Wu | |
| 97. | A Head-to Head Comparison of Risankizumab and Ustekinumab as Second-Line Therapy in Moderate to Severely Active Crohn’s Disease | Pavel S. Roshanov, Reena Khanna | |
| 98. | Proteomic Biomarkers in Serum Predict Villous Atrophy Development in Asymptomatic Potential Celiac Disease Children at Time of Diagnosis | Renata Auricchio, Roberta Mandile, Janneke Samsom, Chiara Esposito, Rossella de Cegli, Luigi Greco, European Laboratory for Food Induced Disease (ELFID) Group | |
| 99. | Portal Fibrosis and the Ductular Reaction: Pathophysiological Role in the Progression of Liver Disease and Translational Opportunities | Vikas Gupta, Tejasav S. Sehrawat, Massimo Pinzani, Mario Strazzabosco | |
| 100. | Reply | Ali Rezaie, Yee Hui Yeo | |
更新于 52 分钟前
近期历史最近 100 条记录
匿名用户只展示最新 100 条榜单历史，更多历史数据请登录后查看，支持时光机按天筛选
Sponsors
